Nova Financial’s Summit Therapeutics SMMT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$5.07K Buy
+300
New +$4.49K ﹤0.01% 651

Other funds holding SMMT

Nova Financial's SMMT Position: Q3 2026 in Review

Nova Financial opened a new position in Summit Therapeutics (SMMT) in Q3 2026: 300 shares worth $5.07K. The stake represents ﹤0.01% of the portfolio and ranks #651 among its holdings.

294 funds tracked by Wall St. Rank hold SMMT as of Q3 2026.

  • Nova Financial held 300 shares of Summit Therapeutics worth $5.07K as of Q3 2026.
  • Summit Therapeutics was a new Nova Financial position in Q3 2026.
  • Summit Therapeutics made up ﹤0.01% of Nova Financial's portfolio in Q3 2026, its #651 holding.
  • 294 funds tracked by Wall St. Rank held Summit Therapeutics as of Q3 2026.

Based on Nova Financial's 13F filing for Q3 2026, filed 4 Nov 2026.